• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

iScience . Evolution of increased positive charge on the SARS-CoV-2 spike protein may be adaptation to human transmission

tetano

Editor, Senior Moderator
iScience


. 2023 Feb 18;106230.
doi: 10.1016/j.isci.2023.106230. Online ahead of print.
Evolution of increased positive charge on the SARS-CoV-2 spike protein may be adaptation to human transmission


Matthew Cotten[SUP] 1 [/SUP], My V T Phan[SUP] 1 [/SUP]



Affiliations

Abstract

The severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2), continues to evolve and infect individuals. The exterior surface of the SARS-CoV-2 virion is dominated by the spike protein and the current work examined spike protein biochemical features that have changed during the 3 years that SARS-CoV-2 has infected humans. Our analysis identified a striking change in spike protein charge, from -8.3 in the original Lineage A and B viruses to -1.26 in most of the current Omicron viruses. We conclude that in addition to immune selection pressure, the evolution of SARS-CoV-2 has also altered viral spike protein biochemical properties that may influence virion survival and promote transmission. Future vaccine and therapeutic development should also exploit and target these biochemical properties.
 
Back
Top Bottom